Literature DB >> 17121198

Fine-needle aspiration of a Xp11.2 translocation/TFE3 fusion renal cell carcinoma metastatic to the lung: report of a case and review of the literature.

Malcolm Schinstine1, Armando C Filie, Carlos Torres-Cabala, Andrea Abati, W Marston Linehan, Maria Merino.   

Abstract

A 57-yr-old woman presented to the National Cancer Institute (NCI) with a history of nephrectomy for a clear cell renal cell carcinoma (RCC), Fuhrman grade 3 of 4 diagnosed 1 yr prior to admission to the NCI. A CT scan done upon admission revealed multiple bilateral lung masses. A CT-guided fine-needle aspiration (FNA) of one of the lung masses revealed a cellular specimen composed primarily of follicular structures surrounding dense hyalinized central cores. The cells in the follicular structures displayed bland nuclei and had granular to vacuolated cytoplasm. Papillary structures were also appreciated. Immunocytochemical studies showed tumor cells that were strongly vimentin and TFE3 positive. Focal staining for AE1/AE3 and CD10 was observed, as was negative staining for EMA. A surgical biopsy specimen reflected the FNA findings and demonstrated a similar immunoprofile. These findings correspond to the recently described Xp11.2 translocation/TFE3 fusion renal cell carcinoma. To our knowledge, this is the first report describing the cytologic features of an Xp11.2 translocation/TFE3 fusion RCC. (C) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17121198     DOI: 10.1002/dc.20548

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  6 in total

1.  Diagnostic pitfall on the histological spectrum of adult-onset renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.

Authors:  Naoto Kuroda; Kazunobu Katto; Yukichi Tanaka; Tadanori Yamaguchi; Kaori Inoue; Masahiko Ohara; Keiko Mizuno; Ondrej Hes; Michal Michal; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2010-08-04       Impact factor: 2.309

2.  Re-evaluation of histological type by immunohistochemical and genetic study of transcription factors (TFE3 and TFEB) of VHL gene mutation-negative clear cell renal cell carcinoma and other special types of renal tumor.

Authors:  Naoto Kuroda; Chiaki Kawada; Kenji Tamura; Makoto Hiroi; Ondrej Hes; Michal Michal; Yukari Wada; Kaori Inoue; Masahiko Ohara; Keiko Mizuno; Taro Shuin; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2011-03-23       Impact factor: 2.309

3.  Xp11.2 translocation renal cell carcinoma with multiple bone metastases: A case report.

Authors:  Jiaju Liu; Zhengming Su; Yifan Li; Duqun Chen; Liangchao Ni; Xiangming Mao; Shangqi Yang; Yongqing Lai
Journal:  Oncol Lett       Date:  2016-02-09       Impact factor: 2.967

4.  Clues to recognition of fumarate hydratase-deficient renal cell carcinoma: Findings from cytologic and limited biopsy samples.

Authors:  Irene Shyu; Leili Mirsadraei; Xiaoyan Wang; Valentina Robila; Rohit Mehra; Jonathan B McHugh; Ying-Bei Chen; Aaron M Udager; Anthony J Gill; Liang Cheng; Mahul B Amin; Oscar Lin; Steven Christopher Smith
Journal:  Cancer Cytopathol       Date:  2018-10-19       Impact factor: 4.264

5.  Xp11.2 translocation renal cell carcinoma occurring during pregnancy with a novel translocation involving chromosome 19: a case report with review of the literature.

Authors:  Henry B Armah; Anil V Parwani; Urvashi Surti; Sheldon I Bastacky
Journal:  Diagn Pathol       Date:  2009-05-18       Impact factor: 2.644

6.  Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.

Authors:  Dinesh Pradhan; Somak Roy; Gabriela Quiroga-Garza; Kathleen Cieply; Alyssa L Mahaffey; Sheldon Bastacky; Rajiv Dhir; Anil V Parwani
Journal:  Diagn Pathol       Date:  2015-09-29       Impact factor: 2.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.